Literature DB >> 28213671

Exome analysis of Smith-Magenis-like syndrome cohort identifies de novo likely pathogenic variants.

Seth I Berger1, Carla Ciccone1, Karen L Simon1, May Christine Malicdan1, Thierry Vilboux1,2, Charles Billington1, Roxanne Fischer1, Wendy J Introne3, Andrea Gropman4, Jan K Blancato5, James C Mullikin6, William A Gahl1,3, Marjan Huizing1, Ann C M Smith7.   

Abstract

Smith-Magenis syndrome (SMS), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the RAI1 gene. We performed exome sequencing on 6 patients with SMS-like phenotypes but without chromosomal abnormalities or RAI1 variants. We identified pathogenic de novo variants in two cases, a nonsense variant in IQSEC2 and a missense variant in the SAND domain of DEAF1, and candidate de novo missense variants in an additional two cases. One candidate variant was located in an alpha helix of Necdin (NDN), phased to the paternally inherited allele. NDN is maternally imprinted within the 15q11.2 Prader-Willi Syndrome (PWS) region. This can help clarify NDN's role in the PWS phenotype. No definitive pathogenic gene variants were detected in the remaining SMS-like cases, but we report our findings for future comparison. This study provides information about the inheritance pattern and recurrence risk for patients with identified variants and demonstrates clinical and genetic overlap of neurodevelopmental disorders. Identification and characterization of ID-related genes that assist in development of common developmental pathways and/or gene-networks, may inform disease mechanism and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28213671      PMCID: PMC5848494          DOI: 10.1007/s00439-017-1767-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  39 in total

1.  Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome.

Authors:  Jill Clayton-Smith; James O'Sullivan; Sarah Daly; Sanjeev Bhaskar; Ruth Day; Beverley Anderson; Anne K Voss; Tim Thomas; Leslie G Biesecker; Philip Smith; Alan Fryer; Kate E Chandler; Bronwyn Kerr; May Tassabehji; Sally-Ann Lynch; Malgorzata Krajewska-Walasek; Shane McKee; Janine Smith; Elizabeth Sweeney; Sahar Mansour; Shehla Mohammed; Dian Donnai; Graeme Black
Journal:  Am J Hum Genet       Date:  2011-11-11       Impact factor: 11.025

2.  Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients.

Authors:  R C Juyal; L E Figuera; X Hauge; S H Elsea; J R Lupski; F Greenberg; A Baldini; P I Patel
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

Review 3.  Histone acetylation in neurodevelopment.

Authors:  Antonio Contestabile; Silvia Sintoni
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

4.  Intellectual disability: novel mutations in DEAF1 cause speech impairment and behavioral problems.

Authors:  S Waltl
Journal:  Clin Genet       Date:  2014-09-16       Impact factor: 4.438

5.  Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems.

Authors:  Anneke T Vulto-van Silfhout; Shivakumar Rajamanickam; Philip J Jensik; Sarah Vergult; Nina de Rocker; Kathryn J Newhall; Ramya Raghavan; Sara N Reardon; Kelsey Jarrett; Tara McIntyre; Joseph Bulinski; Stacy L Ownby; Jodi I Huggenvik; G Stanley McKnight; Gregory M Rose; Xiang Cai; Andy Willaert; Christiane Zweier; Sabine Endele; Joep de Ligt; Bregje W M van Bon; Dorien Lugtenberg; Petra F de Vries; Joris A Veltman; Hans van Bokhoven; Han G Brunner; Anita Rauch; Arjan P M de Brouwer; Gemma L Carvill; Alexander Hoischen; Heather C Mefford; Evan E Eichler; Lisenka E L M Vissers; Björn Menten; Michael W Collard; Bert B A de Vries
Journal:  Am J Hum Genet       Date:  2014-04-10       Impact factor: 11.025

6.  Mutations in RAI1 associated with Smith-Magenis syndrome.

Authors:  Rebecca E Slager; Tiffany Lynn Newton; Christopher N Vlangos; Brenda Finucane; Sarah H Elsea
Journal:  Nat Genet       Date:  2003-03-24       Impact factor: 38.330

7.  Sleep disordered breathing in patients with Prader-Willi syndrome: A multicenter study.

Authors:  Martino Pavone; Valeria Caldarelli; Sonia Khirani; Marina Colella; Adriana Ramirez; Guillaume Aubertin; Antonino Crinò; Frédéric Brioude; Frédérique Gastaud; Nicole Beydon; Michèle Boulé; Lisa Giovannini-Chami; Renato Cutrera; Brigitte Fauroux
Journal:  Pediatr Pulmonol       Date:  2015-04-07

8.  Two binding partners cooperate to activate the molecular motor Kinesin-1.

Authors:  T Lynne Blasius; Dawen Cai; Gloria T Jih; Christopher P Toret; Kristen J Verhey
Journal:  J Cell Biol       Date:  2007-01-01       Impact factor: 10.539

9.  A general framework for estimating the relative pathogenicity of human genetic variants.

Authors:  Martin Kircher; Daniela M Witten; Preti Jain; Brian J O'Roak; Gregory M Cooper; Jay Shendure
Journal:  Nat Genet       Date:  2014-02-02       Impact factor: 38.330

10.  Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomics.

Authors:  Maria Nicla Loviglio; Christine R Beck; Janson J White; Marion Leleu; Tamar Harel; Nicolas Guex; Anne Niknejad; Weimin Bi; Edward S Chen; Isaac Crespo; Jiong Yan; Wu-Lin Charng; Shen Gu; Ping Fang; Zeynep Coban-Akdemir; Chad A Shaw; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; Jacques Rougemont; Ioannis Xenarios; James R Lupski; Alexandre Reymond
Journal:  Genome Med       Date:  2016-11-01       Impact factor: 11.117

View more
  10 in total

1.  Functional analysis of novel DEAF1 variants identified through clinical exome sequencing expands DEAF1-associated neurodevelopmental disorder (DAND) phenotype.

Authors:  Li Chen; Philip J Jensik; Joseph T Alaimo; Magdalena Walkiewicz; Seth Berger; Elizabeth Roeder; Eissa A Faqeih; Jonathan A Bernstein; Ann C M Smith; Sureni V Mullegama; David W Saffen; Sarah H Elsea
Journal:  Hum Mutat       Date:  2017-09-23       Impact factor: 4.878

2.  De Novo KAT5 Variants Cause a Syndrome with Recognizable Facial Dysmorphisms, Cerebellar Atrophy, Sleep Disturbance, and Epilepsy.

Authors:  Jonathan Humbert; Smrithi Salian; Periklis Makrythanasis; Gabrielle Lemire; Justine Rousseau; Sophie Ehresmann; Thomas Garcia; Rami Alasiri; Armand Bottani; Sylviane Hanquinet; Erin Beaver; Jennifer Heeley; Ann C M Smith; Seth I Berger; Stylianos E Antonarakis; Xiang-Jiao Yang; Jacques Côté; Philippe M Campeau
Journal:  Am J Hum Genet       Date:  2020-08-20       Impact factor: 11.025

3.  De Novo Variants in MAPK8IP3 Cause Intellectual Disability with Variable Brain Anomalies.

Authors:  Konrad Platzer; Heinrich Sticht; Stacey L Edwards; William Allen; Kaitlin M Angione; Maria T Bonati; Campbell Brasington; Megan T Cho; Laurie A Demmer; Tzipora Falik-Zaccai; Candace N Gamble; Yorck Hellenbroich; Maria Iascone; Fernando Kok; Sonal Mahida; Hanna Mandel; Thorsten Marquardt; Kirsty McWalter; Bianca Panis; Alexander Pepler; Hailey Pinz; Luiza Ramos; Deepali N Shinde; Constance Smith-Hicks; Alexander P A Stegmann; Petra Stöbe; Constance T R M Stumpel; Carolyn Wilson; Johannes R Lemke; Nataliya Di Donato; Kenneth G Miller; Rami Jamra
Journal:  Am J Hum Genet       Date:  2019-01-03       Impact factor: 11.025

4.  Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.

Authors:  Sébastien Küry; Frédéric Ebstein; Alice Mollé; Thomas Besnard; Ming-Kang Lee; Virginie Vignard; Tiphaine Hery; Mathilde Nizon; Grazia M S Mancini; Jacques C Giltay; Benjamin Cogné; Kirsty McWalter; Wallid Deb; Hagar Mor-Shaked; Hong Li; Rhonda E Schnur; Ingrid M Wentzensen; Anne-Sophie Denommé-Pichon; Cynthia Fourgeux; Frans W Verheijen; Eva Faurie; Rachel Schot; Cathy A Stevens; Daphne J Smits; Eileen Barr; Ruth Sheffer; Jonathan A Bernstein; Chandler L Stimach; Eliana Kovitch; Vandana Shashi; Kelly Schoch; Whitney Smith; Richard H van Jaarsveld; Anna C E Hurst; Kirstin Smith; Evan H Baugh; Suzanne G Bohm; Emílie Vyhnálková; Lukáš Ryba; Capucine Delnatte; Juanita Neira; Dominique Bonneau; Annick Toutain; Jill A Rosenfeld; Séverine Audebert-Bellanger; Brigitte Gilbert-Dussardier; Sylvie Odent; Frédéric Laumonnier; Seth I Berger; Ann C M Smith; Franck Bourdeaut; Marc-Henri Stern; Richard Redon; Elke Krüger; Raphaël Margueron; Stéphane Bézieau; Jeremie Poschmann; Bertrand Isidor
Journal:  Am J Hum Genet       Date:  2022-01-19       Impact factor: 11.043

Review 5.  RAI1 gene mutations: mechanisms of Smith-Magenis syndrome.

Authors:  Mariateresa Falco; Sonia Amabile; Fabio Acquaviva
Journal:  Appl Clin Genet       Date:  2017-11-03

6.  Identification of a de novo splicing variant in the Coffin-Siris gene, SMARCE1, in a patient with Angelman-like syndrome.

Authors:  Cinthia Aguilera; Elisabeth Gabau; Steve Laurie; Neus Baena; Sophia Derdak; Núria Capdevila; Ariadna Ramirez; Veronica Delgadillo; Maria Jesus García-Catalan; Carme Brun; Miriam Guitart; Anna Ruiz
Journal:  Mol Genet Genomic Med       Date:  2018-12-11       Impact factor: 2.183

7.  Molecular basis for phenotypic similarity of genetic disorders.

Authors:  Vijay Kumar Pounraja; Santhosh Girirajan
Journal:  Genome Med       Date:  2019-04-23       Impact factor: 11.117

8.  Heterozygous loss of function of IQSEC2/Iqsec2 leads to increased activated Arf6 and severe neurocognitive seizure phenotype in females.

Authors:  Matilda R Jackson; Karagh E Loring; Claire C Homan; Monica Hn Thai; Laura Määttänen; Maria Arvio; Irma Jarvela; Marie Shaw; Alison Gardner; Jozef Gecz; Cheryl Shoubridge
Journal:  Life Sci Alliance       Date:  2019-08-22

Review 9.  Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.

Authors:  Berardo Rinaldi; Roberta Villa; Alessandra Sironi; Livia Garavelli; Palma Finelli; Maria Francesca Bedeschi
Journal:  Genes (Basel)       Date:  2022-02-11       Impact factor: 4.096

10.  IQSEC2-related encephalopathy in males and females: a comparative study including 37 novel patients.

Authors:  Cyril Mignot; Aoife C McMahon; Claire Bar; Philippe M Campeau; Claire Davidson; Julien Buratti; Caroline Nava; Marie-Line Jacquemont; Marilyn Tallot; Mathieu Milh; Patrick Edery; Pauline Marzin; Giulia Barcia; Christine Barnerias; Claude Besmond; Thierry Bienvenu; Ange-Line Bruel; Ledia Brunga; Berten Ceulemans; Christine Coubes; Ana G Cristancho; Fiona Cunningham; Marie-Bertille Dehouck; Elizabeth J Donner; Bénédicte Duban-Bedu; Christèle Dubourg; Elena Gardella; Julie Gauthier; David Geneviève; Stéphanie Gobin-Limballe; Ethan M Goldberg; Eveline Hagebeuk; Fadi F Hamdan; Miroslava Hančárová; Laurence Hubert; Christine Ioos; Shoji Ichikawa; Sandra Janssens; Hubert Journel; Anna Kaminska; Boris Keren; Marije Koopmans; Caroline Lacoste; Petra Laššuthová; Damien Lederer; Daphné Lehalle; Dragan Marjanovic; Julia Métreau; Jacques L Michaud; Kathryn Miller; Berge A Minassian; Joannella Morales; Marie-Laure Moutard; Arnold Munnich; Xilma R Ortiz-Gonzalez; Jean-Marc Pinard; Darina Prchalová; Audrey Putoux; Chloé Quelin; Alyssa R Rosen; Joelle Roume; Elsa Rossignol; Marleen E H Simon; Thomas Smol; Natasha Shur; Ivan Shelihan; Katalin Štěrbová; Emílie Vyhnálková; Catheline Vilain; Julie Soblet; Guillaume Smits; Samuel P Yang; Jasper J van der Smagt; Peter M van Hasselt; Marjan van Kempen; Sarah Weckhuysen; Ingo Helbig; Laurent Villard; Delphine Héron; Bobby Koeleman; Rikke S Møller; Gaetan Lesca; Katherine L Helbig; Rima Nabbout; Nienke E Verbeek; Christel Depienne
Journal:  Genet Med       Date:  2018-09-12       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.